LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
4.310
-0.085 (-1.93%)
At close: Oct 29, 2024, 4:00 PM
4.237
-0.073 (-1.70%)
After-hours: Oct 29, 2024, 4:46 PM EDT
LifeMD Revenue
LifeMD had revenue of $50.66M in the quarter ending June 30, 2024, with 40.94% growth. This brings the company's revenue in the last twelve months to $178.28M, up 38.63% year-over-year. In the year 2023, LifeMD had annual revenue of $152.55M with 28.15% growth.
Revenue (ttm)
$178.28M
Revenue Growth
+38.63%
P/S Ratio
0.92
Revenue / Employee
$844,928
Employees
211
Market Cap
185.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | 12.47M | 4.14M | 49.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
TruBridge | 336.56M |
Adaptimmune Therapeutics | 141.46M |
NeuroPace | 71.82M |
Senseonics Holdings | 24.04M |
MediWound | 20.14M |
Vaxart | 13.93M |
Profound Medical | 7.88M |
LFMD News
- 5 weeks ago - LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 7 weeks ago - LifeMD: Selling WorkSimpli Could Be A Catalyst - Seeking Alpha
- 2 months ago - LifeMD to Participate in Three Investor Conferences During September - GlobeNewsWire
- 2 months ago - LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - LifeMD Reports Second Quarter 2024 Results - GlobeNewsWire
- 3 months ago - LifeMD: High Growth GLP-1 Telehealth Play At A Discount - Seeking Alpha
- 4 months ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 5 months ago - LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare - Seeking Alpha